ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025
Anatomical factors behind acquired primary nasolacrimal duct obstruction and acute dacryocystitis.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep Learning-Based Automated Segmentation and Multi-Parametric Quantitative Assessment of the Lacrimal Drainage System on CT-DCG.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the nasolacrimal and nasal anatomical parameters in cases of acquired primary nasolacrimal duct obstruction and acute dacryocystitis.
methodsThe study included 62 eyes of 31 patients. The eyes were divided into three groups: Group A, comprising eyes presenting with acute dacryocystitis; Group B, comprising eyes with nasolacrimal duct obstruction but no previous episodes of dacryocystitis; and Group C, comprising eyes with an patent nasolacrimal duct. The coronal, axial, and sagittal computed tomography images of the cases were examined to assess parameters such as the canal's entry and exit, the narrowest transverse and anteroposterior diameters, the anatomical type of the canal, inferior turbinate thickness, the angle between the inferior turbinate and the medial maxillary wall, and the direction of septal deviation.
resultsNo significant difference was found in any parameter when comparing eyes with acquired primary nasolacrimal duct obstruction to the contralateral eyes without obstruction (p > 0.05). Among the three groups, eyes with acute dacryocystitis (Group A) had significantly wider exit transverse and narrowest anteroposterior diameters compared to the other two groups (p = 0.000, p = 0.001, and p = 0.006, p = 0.042), with the narrowest transverse diameter also being significantly wider compared to Group B (p = 0.007). The angle of the inferior turbinate was significantly lower in Group A compared to Group B (p = 0.038). There was no significant difference between the groups regarding the anatomical type of the canal (p = 0.981).
conclusionWhile anatomical parameters do not show significant differences between eyes with primary acquired nasolacrimal duct obstruction and those without obstruction in the same individual, the wider canal diameters in eyes with acute dacryocystitis suggest that secondary changes associated with dacryocystitis or a predisposition to dacryocystitis might be present in eyes with nasolacrimal duct obstruction.
Indexed as
Identifiers
39757266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.